SQ HDM sublingual immunotherapy tablet for the treatment of HDM allergic rhinitis and asthma improves subjective sleepiness and insomnia: an exploratory analysis of the real-life CARIOCA study
CONCLUSION: In patients with HDM AR and/or asthma associated sleep disorders, an improvement in subjective insomnia and sleepiness was observed after one year of treatment with the SQ HDM SLIT-tablet in a real-life setting.PMID:37669078 | DOI:10.18176/jiaci.0934
Source: Journal of Investigational Allergology and Clinical Immunology - Category: Allergy & Immunology Authors: D Jaffuel E Serrano C Leroyer A Chartier P Demoly Source Type: research
More News: Allergy | Allergy & Immunology | Asthma | Corticosteroid Therapy | Hay Fever | Immunotherapy | Insomnia | Respiratory Medicine | Sleep Disorders | Sleep Medicine | Study